EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    5.1.3.19 | Breast Neoplasms |
31972438 |
Dermatan sulfate epimerase 1 expression and mislocalization may interfere with dermatan sulfate synthesis and breast cancer cell growth. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
1
3
0 |
| 5.1.3.19 | Carcinoma |
11920522 |
Expression of tumor rejection antigens in colorectal carcinomas. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 5.1.3.19 | Carcinoma |
16505484 |
Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2. |
ongoing research
unassigned |
3
0 |
| 5.1.3.19 | Carcinoma, Hepatocellular |
22830596 |
Expression of chondroitin-glucuronate C5-epimerase and cellular immune responses in patients with hepatocellular carcinoma. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
3
4
4
4 |
| 5.1.3.19 | Carcinoma, Hepatocellular |
30906633 |
DSE regulates the malignant characters of hepatocellular carcinoma cells by modulating CCL5/CCR1 axis. |
causal interaction
diagnostic usage
unassigned |
3
1
0 |
| 5.1.3.19 | chondroitin-glucuronate 5-epimerase deficiency |
32130795 |
Delineation of musculocontractural Ehlers-Danlos Syndrome caused by dermatan sulfate epimerase deficiency. |
causal interaction
unassigned |
4
0 |
| 5.1.3.19 | Colorectal Neoplasms |
11920522 |
Expression of tumor rejection antigens in colorectal carcinomas. |
diagnostic usage
ongoing research
unassigned |
3
4
0 |
| 5.1.3.19 | Ehlers-Danlos Syndrome |
23704329 |
Loss of dermatan sulfate epimerase (DSE) function results in musculocontractural Ehlers-Danlos syndrome. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
1
1
0 |
| 5.1.3.19 | Ehlers-Danlos Syndrome |
32130795 |
Delineation of musculocontractural Ehlers-Danlos Syndrome caused by dermatan sulfate epimerase deficiency. |
causal interaction
unassigned |
4
0 |
| 5.1.3.19 | Endometrial Neoplasms |
11092984 |
Expression of tumor-rejection antigens in gynecologic cancers. |
diagnostic usage
unassigned |
2
0 |
